J Korean Acad Fam Med Search

CLOSE


Korean J Fam Med > Epub ahead of print
Baek, Park, Kim, Kim, Lee, Shin, Cho, Kim, and Choi: Association between Use of Combustible Cigarettes and Noncombustible Nicotine or Tobacco Products and Health-Related Quality of Life in Korean Men: A Nationwide Population-Based Study

Abstract

Background

Although the association between smoking and health-related quality of life (HRQoL) has been established, the effects of tobacco products, including combustible cigarettes (CCs) and non-combustible nicotine or tobacco products (NNTPs), on HRQoL remain unclear. This study examined the association between tobacco use and HRQoL in Korean men.

Methods

Data from the Korea National Health and Nutrition Examination Survey conducted between 2013 and 2020 were analyzed. A total of 16,429 male participants aged ≥19 years completed the European Quality of Life-5 Dimensions (EQ-5D). Impaired HRQoL was defined as scoring in the lowest 20% of the EQ-5D index and having some or extreme problems in the following five domains of the EQ-5D: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Multiple logistic regression was conducted to evaluate the risk of impaired HRQoL in current tobacco users.

Results

Current tobacco users exhibited a significantly higher risk of impaired HRQoL compared with never users (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.05–1.92). Compared to never users, current tobacco users reported more problems with mobility and pain/discomfort (all P<0.05). Moreover, compared with former tobacco users, current tobacco users had a higher risk of impaired HRQoL (OR, 1.60; 95% CI, 1.18–2.17). Compared to former tobacco users, current tobacco users reported more problems with mobility and pain/discomfort (all P<0.05).

Conclusion

Use of CCs and NNTPs is associated with impaired HRQoL in Korean men. Therefore, further interventions for lifestyle modification and smoking cessation treatments are required to reduce the risk of impaired HRQoL among current tobacco users.

INTRODUCTION

Quality of life (QOL) is a crucial aspect of overall well-being because it reflects happiness and satisfaction in life. The concept of QOL is broad and complex, including subjective assessments of positive and negative factors in life [1]. Traditionally, data on disease morbidity and mortality have been key indicators for obtaining health-related information. Furthermore, health has been recognized as an important aspect of QOL, raising interest in health-related QOL (HRQoL) which refers to an individual’s subjective perception of their physical and mental health over a period [2]. By contrast, individuals with impaired HRQoL may experience poor health conditions in various aspects, heightened vulnerability to diseases, and an increased economic burden caused by diseases. Therefore, identifying the risk factors associated with impaired HRQoL is important for preventing and reducing the negative impacts on individuals and public health [3].
Current evidence suggests that combustible cigarette (CC) smoking is a risk factor associated with impaired HRQoL [4-6]. While the rate of CC smoking has declined worldwide over the past few years, the emergence of noncombustible nicotine or tobacco products (NNTPs) has recently gained popularity [7]. NNTPs are new types of nicotine products, including electronic cigarettes (ECs) that vaporize liquid containing nicotine, and heated tobacco products (HTPs) that heat tobacco without combustion [8]. The potential harm of NNTPs has often been overlooked, due to the perception that they are less harmful than CCs and can help with quitting smoking [9,10]. CC smokers who start using NNTPs in an attempt to quit smoking become tobacco users of more than one tobacco products [11]. Tobacco use of CCs and NNTPs may result in higher exposure to nicotine and chemicals compared to using a single product. Hence, it can elevate the risk of nicotine dependence and tobacco-related health consequences [12,13], which, in turn, can negatively impact HRQoL.
Considering the limited research available on the association between tobacco use and HRQoL, this study used nationwide population-based data to investigate the association between tobacco use and HRQoL among Korean men.

METHODS

1. Study Design

This study used data from the Korea National Health and Nutrition Examination Survey (KNHANES), which evaluates the nutritional and health status of the Korean population. The survey comprised nutritional questionnaires, health examinations, and interviews. The KNHANES data are in the public domain and do not contain individually identifiable information. All participants signed an informed consent form before the survey, which was approved by the Institutional Review Board of the Korean Centers for Disease Control and Prevention (IRB No.: 2013-07CON-03-4C, 2013-12EXP-03-5C, 2018-01-03-PA, 2018-01-03-C-A and 2018-01-03-2C-A). In this study, data from the KNHANES conducted between 2013 and 2020 were analyzed (Figure 1). Female participants were excluded (n=28,051) because of the low smoking rate among Korean women and the large difference between self-reported and actual smoking status. Of the 22,111 men, we excluded those who did not complete the European Quality of Life-5 Dimensions (EQ-5D) (n=2,846) and those with missing values for other variables (n=2,836). Overall, 16,429 male participants aged ≥19 years were included in the study and were classified as follows: never users (n=4,481), former users (n=6,550), CC smokers (n=4,422), NNTP users (n=267), and current tobacco users (n=709).

2. Tobacco Use Status

The tobacco use status of participants was assessed using a self-report survey. Never users were classified as individuals who had smoked less than 100 CCs and had neither smoked CCs nor used NNTPs throughout their lives. Former users were classified as individuals who had smoked more than 100 CCs or had used NNTPs at some point but were not currently using either. CC smokers were classified as individuals who had smoked more than 100 CCs throughout their lives and currently smoked occasionally or daily, but had not used NNTPs throughout their lives. NNTP users were classified as individuals who had used ECs or HTPs throughout their lives and were currently using, but had not smoked CCs throughout their lives. EC users were classified as individuals currently using ECs. HTP users were classified as individuals currently using HTPs. Current tobacco users were defined as individuals who used more than one tobacco product, including CCs and NNTPs.

3. Covariates

The demographic variables analyzed in this study included age, educational level, household income level, residential area, marital status, occupation, body mass index (BMI), and obesity status. Age was categorized into four groups: 19–29, 30–39, 40–49, and ≥50 years. Educational qualifications were categorized based on high school graduation. Household income levels were classified as either “high” or “low” based on monthly income. Participants living in rural areas, specifically in “eup” or “myeon,” were classified as rural residents, whereas those living in “dong” were classified as urban residents. Participants were categorized as either “single” or “married” based on their marital status. Homemakers and students were classified as unemployed. “Simple labor workers,” “service and sales workers,” “technical staff and equipment- and machine-operating workers and machine-assembling workers,” and “skilled workers in agriculture, forestry, and fisheries” were classified as manual workers. “Office workers” and “managers, specialists, and related workers” were classified as non-manual workers. Individuals with BMI >25.0 kg/m2 were classified as obese.
Regular physical activity was defined as engaging in more than 20 minutes of intense activity for 3 days or more or engaging in more than 30 minutes of moderate activity for more than 5 days per week. Alcohol consumption was defined as consuming alcohol at least once per month. In terms of mental health, stress status was defined as moderate or extreme levels of stress according to individuals’ self-perceived stress levels, and depression was defined as individuals who had experienced a depressed mood for more than 2 weeks throughout the past years. Participants were categorized based on a physician’s diagnosis of hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases (including myocardial infarction, angina, and stroke), and cancer (stomach, liver, colon, lung, thyroid, and other cancers) using a self-report survey.

4. Health-Related Quality of Life Measurement

The EQ-5D was used to measure the HRQoL. Developed by the EuroQol Group in the 1980s, the EQ-5D is a generic instrument to evaluate and compare factors associated with HRQoL [14]. Participants’ current health status was assessed using five domains of the EQ-5D: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The five domains were categorized into three response levels: no problems (1), some problems (2), and extreme problems (3), generating values for 243 health conditions. The EQ-5D index score ranges between 0 and 1, with higher scores indicating better health conditions [15]. No established cut-off value for the EQ-5D index score exists to determine impaired HRQoL. In this study, EQ-5D index scores were divided into five quantiles. Participants who scored below the lowest 20% and reported some or “some problems” or “extreme problems” in the EQ-5D domains were classified as having impaired HRQoL.

5. Statistical Analysis

Data from the KNHANES were used, and integrated weights were calculated and analyzed to ensure representation of the Korean population. One-way analysis of variance was used to examine continuous variables, whereas the chi-square test was employed to analyze categorical variables. We used multiple logistic regression analysis to calculate odds ratios (ORs) and 95% confidence intervals (CI) to examine the association between tobacco use and impaired HRQoL. Four models were used to adjust for different covariates: model 1 (no covariate unadjusted), model 2 (age was adjusted), model 3 (education, household income, residential area, marital status, occupation, obesity, physical activity, alcohol consumption, and the covariate used in model 2 were adjusted), and model 4 (stress, depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases, cancers, and the covariates used in model 3 were adjusted). Statistical significance was defined as P<0.05. Statistical analyses were performed using the SAS ver. 9.3 (SAS Institute Inc., Cary, NC, USA).

RESULTS

1. Baseline Characteristics

Table 1 illustrates the characteristics of 16,429 men aged ≥19 years. Among the participants, 4,481 (30.5%) were categorized as never users, 6,550 (34.5%) as former users, 4,422 (27.8%) as CC smokers, 267 (1.8%) as NNTP users, and 709 (5.4%) as current tobacco users. The mean age of current tobacco users was the lowest, and their mean BMI was higher than that of the other groups (P<0.001). Current tobacco users were mainly aged 19–29 years, above high school graduates, high-income earners, urban residents, married, manual workers, not obese, did not engage in regular physical activity, consumed alcohol at least once a month, and had a low stress status (P<0.001). Current tobacco users exhibited significantly lower prevalence rates of depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases, and cancer (all P<0.001).

2. Distribution of the European Quality of Life-5 Dimensions

The mean EQ-5D index score of current tobacco users was significantly lower than that of never users (P<0.001). Among the five domains of the EQ-5D, current tobacco users reported more problems with mobility, usual activities, and pain/discomfort than never users (all P<0.001). No significant differences were observed in anxiety/depression domains (Table 2).

3. Association between Smoking Status and Impaired Health-Related Quality of Life

The multiple logistic regression analysis showed that current tobacco users had a significantly higher risk of impaired HRQoL compared with never users (model 4: OR, 1.42; 95% CI, 1.05–1.92) whereas no significant difference was observed among former users, CC smokers, and NNTP users. Moreover, compared to never users, current tobacco users reported more problems with mobility and pain/discomfort in Model 4 (all P<0.05). Compared to never users, CC smokers reported more problems with mobility, self-care, and usual activities in model 4 (all P<0.05). Compared to never users, the adjusted OR for mobility was higher in current tobacco users (OR, 2.04; 95% CI, 1.33–3.13) than in CC smokers (OR, 1.41; 95% CI, 1.16–1.71) based on Model 4. No significant differences in impaired HRQoL and problems within the EQ-5D domains were observed between NNTP users and never users (Table 3).
Among participants with a history of tobacco use, current tobacco users had a significantly higher risk of impaired HRQoL than former tobacco users (model 4: OR, 1.60; 95% CI, 1.18–2.17). Compared to former users, CC smokers had a higher risk of impaired HRQoL (model 4: OR, 1.17; 95% CI, 1.02–1.34). Additionally, compared to former tobacco users, current tobacco users reported more problems with mobility and pain/discomfort in model 4 (all P<0.05). Compared to former users, CC smokers reported more problems with mobility and usual activities in model 4 (all P<0.05). Compared to former tobacco users, the adjusted OR for mobility was higher in current tobacco users (OR, 1.84; 95% CI, 1.2–2.78) than in CC smokers (OR, 1.21; 95% CI, 1.02–1.42) based on Model 4. No significant differences in impaired HRQoL and problems within the EQ-5D domains were found between NNTP users and former users (Model 4) (Table 4).
As the KNHANES data from 2019 classified NNTP users into EC and HTP users, we examined the association of HRQoL among current tobacco users, EC users, HTP users, CC smokers, former users, and never users between 2019 and 2020. The mean EQ-5D index score of current tobacco users was significantly lower than that of EC, HTP, and never users (P<0.001) (Supplement 1). Supplements 2 and 3 show the association between impaired HRQoL and tobacco use.

4. Subgroup Analysis

Stratified subgroup analyses were performed according to age, education, occupation, residential area, household income level, marital status, regular physical activity, alcohol consumption, obesity, stress, depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, and cancer (Table 5). The association of impaired HRQoL among never users and current tobacco users did not differ across most subgroups, including age, education, occupation, household income level, marital status, regular physical activity, alcohol consumption, stress, depression, hypertension, diabetes mellitus, cardiovascular diseases, and cancers (P for interaction; 0.177, 0.525, 0.394, 0.779, 0.231, 0.118, 0.486, 0.862, 0.512, 0.113, 0.547, 0.134, 0.093, respectively), except for some subgroups such as residential area, obesity, and dyslipidemia (P for interaction; 0.022, 0.021, 0.026, respectively).

DISCUSSION

This nationwide population-based study demonstrated that tobacco use was associated with impaired HRQoL in Korean men. Compared with never users and former users, current tobacco users exhibited a significantly higher risk of impaired HRQoL and reported more problems with mobility and pain/discomfort.
Previous studies have found an association between CC smoking and impaired HRQoL [16-18]. A study based on the general English population reported that smoking was negatively associated with HRQoL. Heavy smokers had a significantly higher risk of experiencing some or severe problems in all five domains of the EQ-5D compared with non-smokers [16]. A recent study conducted in China suggested that smokers had 11.65% lower average probability of having a higher HRQoL compared with non-smokers [17]. Another study based on the KNHANES revealed that current smokers had higher adjusted ORs for impaired HRQoL compared with former smokers (OR, 1.21; 95% CI, 1.21–1.21) and non-smokers (OR, 1.17; 95% CI, 1.17–1.17). Moreover, compared to former smokers and non-smokers, current smokers had more problems in all domains of the EQ-5D (all P<0.001) [18]. However, no study has examined the association between tobacco use and HRQoL. Notably, this is the first study to examine whether tobacco use is associated with HRQoL among Korean men.
The positive association between tobacco use and impaired HRQoL can be attributed to several factors. Current tobacco users are exposed to higher levels of nicotine and chemicals, which increase oxidative stress and the release of inflammatory cytokines [19,20]. These inflammatory changes can negatively affect individuals’ health status and increase the risk of tobacco-related diseases such as metabolic syndrome, respiratory diseases, and cardiovascular diseases [20-22]. The diseases resulting from tobacco use can cause difficulties in any of the five domains of the EQ-5D. Additionally, long-term nicotine intake from using tobacco products can induce the desensitization of nicotinic acetylcholine receptors in the brain and a decrease in neurotransmitter release, particularly for serotonin and dopamine [23,24]. This ultimately leads to the development of anxiety and depression [25,26], indicating that current tobacco users may be more vulnerable to these mental health issues than never users [27]. Therefore, the findings of this study showed that tobacco use has a significant impact on certain domains of the EQ-5D in relation to impaired HRQoL.
In this study, current tobacco users were shown to have a higher risk of impaired HRQoL than former tobacco users. Specifically, current tobacco users reported more problems with mobility and pain/discomfort than did former users. These findings suggest that individuals who continue to use more than one tobacco product, including CCs and NNTPs, are more likely to have impaired HRQoL than those who quit smoking. Furthermore, smokers who successfully quit smoking experience a significant improvement in their HRQoL [28,29]. Therefore, it is crucial for public health efforts to provide accurate information on tobacco use, especially regarding the uncertain perception of NNTPs as a smoking cessation tool. In addition, regulations on access to CCs and NNTPs as well as tobacco bans and pricing strategies can promote public health.
Although this study offers valuable insights, some limitations must be acknowledged. As this was a cross-sectional study, causal relationships could not be established. There is a potential for bias in cases where underlying health conditions lead individuals to adopt tobacco use. Reliance on self-report surveys introduces recall bias and the possibility of participant underestimation. The omission of nicotine levels and nicotine dependence measurements among current tobacco users calls for further research to categorize such users more comprehensively.
Despite these limitations, this study had several strengths. It harnessed a large, representative dataset from the KNHANES, which enhanced the reliability and generalizability of the results. The self-reported survey data enabled the specific classification of current tobacco users. The study’s utilization of the validated EQ-5D facilitated a comprehensive evaluation of the association between tobacco use and HRQoL. Furthermore, adjustments for various confounding factors yielded statistically significant results, which were attributed to the analysis.
In conclusion, use of CCs and NNTPs was associated with impaired HRQoL in Korean men. Therefore, further interventions for lifestyle modification and smoking cessation treatments are required to reduce the risk of impaired HRQoL among current tobacco users. Additionally, continuous HRQoL assessments for current tobacco users are recommended to evaluate the effectiveness of new regulations in reducing health disparities and improving overall HRQoL.

Notes

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

This research was supported and funded byKorea Medical Institute Research Fund (Q2225621).

SUPPLEMENTARY MATERIALS

Supplementary materials can be found via https://doi.org/10.4082/kjfm.23.0179.
Supplement 1.
Distribution of EQ-5D according to tobacco use status (current tobacco users, EC users, HTP users, CC smokers, former users, and never users)
kjfm-23-0179-Supplementary-1.pdf
Supplement 2.
Association of impaired HRQoL according to tobacco use status (current tobacco users, EC users, HTP users, CC smokers, former users, and never users)
kjfm-23-0179-Supplementary-2.pdf
Supplement 3.
Association between impaired HRQoL and tobacco use (current tobacco users, EC users, HTP users, CC smokers, and former users)
kjfm-23-0179-Supplementary-3.pdf

Figure. 1.
Flowchart of the study participants. EQ-5D, European Quality of Life-5 Dimensions; NNTP, noncombustible nicotine or tobacco product; CC, combustible cigarette.
kjfm-23-0179f1.jpg
Table 1.
Baseline characteristics of the study population
Characteristic Current tobacco users (n=709) NNTP users (n=267) CC smokers (n=4,422) Former users (n=6,550) Never users (n=481) P-value
Mean age (y) 36.2±0.5 38.7±0.7 46.4±0.3 54.5±0.2 39.4±0.3 <0.001
Age (y) <0.001
 19–29 199 (32.5) 49 (19.3) 390 (13.3) 185 (5.0) 1,246 (36.3)
 30–39 218 (31.8) 89 (35.4) 711 (18.9) 499 (10.1) 880 (21.9)
 40–49 173 (23.0) 86 (33.8) 1,024 (26.0) 998 (20.6) 652 (14.9)
 ≥50 119 (12.7) 43 (11.5) 2,297 (41.8) 4,868 (64.3) 1,703 (26.9)
Education <0.001
 <High school 55 (6.6) 18 (4.7) 1,117 (19.4) 2,186 (26.0) 736 (10.5)
 ≥High school 654 (93.4) 249 (95.3) 3,305 (80.6) 4,364 (74.0) 3,745 (89.5)
Household income level <0.001
 Low 205 (26.9) 78 (30.0) 1,872 (38.2) 2,957 (38.8) 1,611 (32.8)
 High 504 (73.1) 189 (70.0) 2,550 (61.8) 3,593 (61.2) 2,870 (67.2)
Residential area <0.001
 Rural 87 (11.1) 33 (10.5) 947 (18.1) 1,353 (17.0) 766 (13.5)
 Urban 622 (88.9) 234 (89.5) 3,475 (81.9) 5,197 (83.0) 3,715 (86.5)
Marital status <0.001
 Single 297 (48.1) 89 (34.2) 847 (24.9) 403 (9.2) 1,612 (45.4)
 Married 412 (51.9) 178 (65.8) 3,575 (75.1) 6,147 (90.8) 2,869 (54.6)
Occupation <0.001
 Unemployed 277 (37.9) 133 (49.4) 1,106 (27.6) 1,593 (29.2) 1,567 (36.9)
 Manual 310 (43.6) 98 (36.8) 2,321 (52.7) 2,840 (45.3) 1,567 (34.0)
 Non-manual 122 (18.5) 36 (13.8) 995 (19.7) 2,117 (25.5) 1,347 (29.1)
Body mass index (kg/m²) 25.4±0.2 25.3±0.2 24.3±0.1 24.6±0.0 24.5±0.1 <0.001
Obesity <0.001
 No 363 (50.9) 132 (51.0) 2,747 (61.3) 3,861 (57.7) 2,730 (60.8)
 Yes 346 (49.1) 135 (49.0) 1,675 (38.7) 2,689 (42.3) 1,751 (39.2)
Regular physical activity <0.001
 No 609 (84.3) 237 (89.3) 4,097 (91.9) 5,744 (86.1) 3,831 (83.9)
 Yes 100 (15.7) 30 (10.7) 325 (8.1) 806 (13.9) 650 (16.1)
Alcohol consumption <0.001
 No 98 (13.5) 52 (21.1) 852 (18.1) 1,927 (26.7) 1,477 (32.2)
 Yes 611 (86.5) 215 (78.9) 3,570 (81.9) 4,623 (73.3) 3,004 (67.8)
Stress 276 (40.3) 85 (30.6) 1,244 (29.8) 1,178 (20.5) 982 (23.3) <0.001
Depression 55 (7.7) 9 (2.6) 203 (4.3) 267 (3.7) 177 (3.8) <0.001
Hypertension 78 (8.1) 37 (12.5) 1,002 (18.6) 2,348 (30.0) 837 (13.2) <0.001
Diabetes mellitus 37 (4.4) 25 (8.0) 474 (8.2) 950 (11.7) 308 (4.8) <0.001
Dyslipidemia 67 (8.8) 27 (10.2) 629 (12.3) 1,393 (19.5) 438 (7.7) <0.001
Cardiovascular diseases 14 (1.8) 5 (1.8) 225 (3.6) 636 (7.7) 175 (2.3) <0.001
Cancers 9 (0.8) 3 (0.7) 116 (2.0) 501 (6.0) 146 (2.3) <0.001

Values are presented as mean±standard error or unweighted numbers (weighted %).

NNTP, noncombustible nicotine or tobacco product; CC, combustible cigarette.

Table 2.
Distribution of the EQ-5D according to tobacco use status
Variable Current tobacco users NNTP users CC smokers Former users Never users P-value
Mean EQ-5D index score 0.97±0.003 0.98±0.003 0.96±0.001 0.96±0.001 0.98±0.001 <0.001
EQ-5D*
 Mobility <0.001
  No problem 666 (93.8) 253 (95.7) 3,909 (91.5) 5,613 (89.0) 4,157 (95.2)
  Problem 43 (6.2) 14 (4.3) 513 (8.5) 937 (11.0) 324 (4.8)
 Self-care <0.001
  No problem 701 (99.1) 265 (99.2) 4,258 (97.3) 6,283 (96.9) 4,383 (98.7)
  Problem 8 (0.9) 2 (0.8) 164 (2.7) 267 (3.1) 98 (1.3)
 Usual activity <0.001
  No problem 687 (96.4) 259 (97.7) 4,123 (94.4) 6,018 (93.8) 4,291 (97.0)
  Problem 22 (3.6) 8 (2.3) 299 (5.6) 532 (6.2) 190 (3.0)
 Pain/discomfort <0.001
  No problem 587 (81.4) 230 (87.0) 3,612 (83.7) 5,256 (82.3) 3,837 (86.7)
  Problem 122 (18.6) 37 (13.0) 810 (16.3) 1,294 (17.7) 644 (13.3)
 Anxiety/depression 0.091
  No problem 655 (92.1) 256 (96.5) 4,058 (92.8) 6,064 (93.5) 4,197 (93.8)
  Problem 54 (7.9) 11 (3.5) 364 (7.2) 486 (6.5) 284 (6.2)

Values are presented as mean±standard error or unweighted numbers (weighted %).

EQ-5D, European Quality of Life-5 Dimensions; NNTP, noncombustible nicotine or tobacco product; CC, combustible cigarette.

* EQ-5D was categorized into three levels: no problem (1); some problems (2); extreme problems (3).

Problem indicates some problems (2) or extreme problems (3).

Table 3.
Association of impaired HRQoL according to tobacco use status
Variable Model 1
Model 2
Model 3
Model 4
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Impaired HRQoL*
 Never users 1 1 1 1
 Former users 1.59 (1.39–1.80) <0.001 0.92 (0.81–0.05) 0.234 1.05 (0.91–1.22) 0.474 1.01 (0.87–1.17) 0.923
 CC smokers 1.40 (1.22–1.62) <0.001 1.14 (0.99–1.31) 0.080 1.27 (1.09–1.48) 0.002 1.14 (0.97–1.33) 0.107
 NNTP users 0.69 (0.43–1.11) 0.128 0.78 (0.47–1.27) 0.312 0.94 (0.57–1.55) 0.814 0.87 (0.52–1.44) 0.579
 Current tobacco users 1.29 (0.98–1.69) 0.065 1.62 (1.22–2.16) 0.001 1.84 (1.38–2.45) <0.001 1.42 (1.05–1.92) 0.022
Problems in EQ-5D
 Mobility
  Never users 1 1 1 1
  Former users 2.43 (2.07–2.86) <0.001 1.14 (0.96–1.36) 0.133 1.23 (1.02–1.48) 0.029 1.18 (0.98–1.42) 0.084
  CC smokers 1.83 (1.53–2.19) <0.001 1.48 (1.23–1.79) <0.001 1.51 (1.25–1.83) <0.001 1.41 (1.16–1.71) 0.001
  NNTP users 0.88 (0.47–1.65) 0.690 1.29 (0.67–2.48) 0.451 1.46 (0.75–2.8) 0.264 1.35 (0.69–2.64) 0.387
  Current tobacco users 1.31 (0.90–1.92) 0.164 2.28 (1.51–3.45) <0.001 2.40 (1.58–3.63) <0.001 2.04 (1.33–3.13) 0.001
 Self-care
  Never users 1 1 1 1
  Former users 2.52 (1.90–3.34) <0.001 1.16 (0.86–1.56) 0.342 1.20 (0.87–1.65) 0.278 1.12 (0.81–1.55) 0.493
  CC smokers 2.17 (1.59–2.96) <0.001 1.80 (1.31–2.46) 0.000 1.77 (1.28–2.44) 0.001 1.60 (1.15–2.23) 0.006
  NNTP users 0.64 (0.15–2.69) 0.546 1.03 (0.24–4.42) 0.974 1.14 (0.26–5.00) 0.865 1.01 (0.22–4.65) 0.990
  Current tobacco users 0.71 (2.29–1.74) 0.451 1.34 (0.55–3.26) 0.517 1.33 (0.54–3.25) 0.534 1.05 (0.42–2.64) 0.923
 Usual activity
  Never users 1 1 1 1
  Former users 2.11 (1.70–2.61) <0.001 1.12 (0.91–1.39) 0.296 1.29 (1.02–1.64) 0.031 1.21 (0.95–1.55) 0.115
  CC smokers 1.89 (1.49–2.40) <0.001 1.53 (1.21–1.95) 0.001 1.76 (1.38–2.25) <0.001 1.61 (1.25–2.06) 0.000
  NNTP users 0.76 (0.34–1.69) 0.495 0.96 (0.42–2.17) 0.913 1.20 (0.52–2.75) 0.670 1.09 (0.46–2.59) 0.851
  Current tobacco users 1.20 (0.70–2.1) 0.512 1.72 (0.99–2.99) 0.056 1.97 (1.12–3.46) 0.019 1.59 (0.89–2.83) 0.120
 Pain/discomfort
  Never users 1 1 1 1
  Former users 1.40 (1.25–1.58) <0.001 1.02 (0.91–1.16) 0.726 1.11 (0.97–1.26) 0.129 1.07 (0.944–1.22) 0.278
  CC smokers 1.27(1.12–1.46) 0.000 1.11 (0.97–1.27) 0.120 1.18 (1.02–1.35) 0.023 1.10 (0.95–1.26) 0.207
  NNTP users 0.97 (0.67–1.42) 0.885 1.01 (0.70–1.48) 0.942 1.15 (0.78–1.70) 0.477 1.09 (0.74–1.62) 0.663
  Current tobacco users 1.49 (1.18–1.89) 0.001 1.65 (1.30–2.09) <0.001 1.79 (1.41–2.28) <0.001 1.56 (1.22–1.98) 0.000
 Anxiety/depression
  Never users 1 1 1 1
  Former users 1.05 (0.87–1.26) 0.604 0.82 (0.68–0.98) 0.028 0.94 (0.77–1.15) 0.553 0.88 (0.71–1.08) 0.208
  CC smokers 1.17 (0.96–1.42) 0.120 1.05 (0.86–1.27) 0.640 1.21 (0.99–1.48) 0.065 0.99 (0.80–1.23) 0.943
  NNTP users 0.55 (0.27–1.10) 0.088 0.57 (0.28–1.13) 0.107 0.69 (0.35–1.39) 0.302 0.61 (0.30–1.24) 0.171
  Current tobacco users 1.31 (0.93–1.84) 0.129 1.41 (0.99–1.99) 0.055 1.64 (1.15–2.34) 0.006 1.07 (0.74–1.57) 0.711

Model 1: unadjusted; model 2: adjusted for age; model 3: additionally adjusted for education, household income level, residential area, marital status, occupation, obesity, physical activity, and alcohol consumption; and model 4: additionally adjusted for stress, depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases, and cancers.

HRQoL, health-related quality of life; OR, odds ratio; CI, confidence interval; EQ-5D, Euro Quality of Life-5 Dimension; CC, combustible cigarette; NNTP, noncombustible nicotine or tobacco product.

* Impaired HRQoL indicates the lowest first 20% of the EQ-5D index scores.

Problems in the EQ-5D indicate some (2) or extreme (3) problems in the EQ-5D domains.

Table 4.
Association of impaired HRQoL according to tobacco use status
Variable Model 1
Model 2
Model 3
Model 4
OR (95% Cl) P-value OR (95% Cl) P-value OR (95% Cl) P-value OR (95% Cl) P-value
Impaired HRQoL*
 Former users 1 1 1 1
 CC smokers 0.89 (0.79–1.00) 0.040 1.36 (1.20–1.54) <0.001 1.25 (1.10–1.42) 0.001 1.17 (1.02–1.34) 0.024
 NNTP users 0.44 (0.27–0.70) 0.001 1.03 (0.63–1.69) 0.911 0.97 (0.59–1.62) 0.920 0.93 (0.56–1.56) 0.792
 Current tobacco users 0.81 (0.63–1.05) 0.116 2.231 (1.68–2.96) <0.001 1.96 (1.47–2.62) <0.001 1.60 (1.18–2.17) 0.003
Problems in EQ-5D
 Mobility
  Former users 1 1 1 1
  CC smokers 0.75 (0.65–0.87) <0.001 1.36 (1.17–1.59) <0.001 1.24 (1.06–1.46) 0.008 1.21 (1.02–1.42) 0.026
  NNTP users 0.36 (0.20–0.67) 0.001 1.25 (0.66–2.38) 0.500 1.23 (0.64–2.36) 0.545 1.18 (0.61–2.29) 0.624
  Current tobacco users 0.54 (0.38–0.78) 0.001 2.25 (1.52–3.34) <0.001 2.05 (1.37–3.07) 0.001 1.84 (1.2–2.78) 0.004
 Self-care
  Former users 1 1 1 1
  CC smokers 0.86 (0.68–1.10) 0.237 1.50 (1.15–1.96) 0.003 1.36 (1.02–1.81) 0.035 1.3 (0.99–1.79) 0.057
  NNTP users 0.26 (0.06–1.06) 0.060 0.82 (0.19–3.52) 0.794 0.81 (0.18–3.59) 0.781 0.78 (0.17–3.61) 0.753
  Current tobacco users 0.28 (0.12–0.67) 0.004 1.07 (0.45–2.54) 0.885 0.93 (0.39–2.23) 0.878 0.82 (0.34–1.98) 0.653
 Usual activity
  Former users 1 1 1 1
  CC smokers 0.90 (0.75–1.08) 0.242 1.41 (1.17–1.69) 0.000 1.30 (1.07–1.58) 0.008 1.27 (1.04–1.54) 0.020
  NNTP users 0.36 (0.16–0.80) 0.012 0.91 (0.40–2.08) 0.821 0.88 (0.37–2.07) 0.763 0.85 (0.35–2.05) 0.716
  Current tobacco users 0.57 (0.34–0.95) 0.031 1.65 (0.99–2.76) 0.056 1.45 (0.84–2.48) 0.180 1.25 (0.72–2.16) 0.424
 Pain/discomfort
  Former users 1 1 1 1
  CC smokers 0.91 (0.81–1.02) 0.110 1.13 (1.00–1.27) 0.057 1.06 (0.94–1.20) 0.351 1.01 (0.89–1.15) 0.841
  NNTP users 0.69 (0.48–1.00) 0.052 1.06 (0.73–1.55) 0.757 1.06 (0.72–1.56) 0.782 1.03 (0.69–1.52) 0.901
  Current tobacco users 1.06 (0.85–1.33) 0.594 1.74 (1.37–2.22) <0.001 1.64 (1.29–2.10) <0.001 1.47 (1.14–1.88) 0.003
 Anxiety/depression
  Former users 1 1 1 1
  CC smokers 1.11 (0.94–1.31) 0.219 1.42 (1.19–1.69) 0.000 1.33 (1.10–1.61) 0.003 1.17 (0.96–1.42) 0.123
  NNTP users 0.52 (0.26–1.04) 0.065 0.85 (0.42–1.72) 0.652 0.780 (0.39–1.63) 0.535 0.75 (0.37–1.55) 0.438
  Current tobacco users 1.24 (0.89–1.73) 0.198 2.18 (1.54–3.10) <0.001 1.94 (1.35–2.79) 0.000 1.35 (0.91–2.00) 0.134

Model 1: unadjusted; model 2: adjusted for age; model 3: additionally adjusted for education, household income level, residential area, marital status, occupation, obesity, physical activity, and alcohol consumption; and model 4: additionally adjusted for stress, depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases, and cancers.

HRQoL, health-related quality of life; OR, odds ratio; CI, confidence interval; EQ-5D, Euro Quality of Life-5 Dimension; CC, combustible cigarette; NNTP, noncombustible nicotine or tobacco product.

* Impaired HRQoL indicates the lowest first 20% of the EQ-5D index scores.

Problems in the EQ-5D indicate some (2) or extreme (3) problems in the EQ-5D domains.

Table 5.
Subgroup analysis of impaired HRQoL* among never users and current tobacco users
Subgroup OR (95% Cl)
P for interaction
Never users Current tobacco users
Age (y) 0.177
 <40 1 1.045 (0.69–1.58)
 ≥40 1 1.52 (1.07–2.17)
Education 0.525
 <High school 1 1.11 (0.55–2.64)
 ≥High school 1 1.42 (1.06–1.91)
Occupation 0.394
 No 1 1.22 (0.75–1.99)
 Yes 1 1.58 (1.13–2.19)
Residential area 0.022
 Urban 1 1.45 (1.09–1.92)
 Rural 1 0.37 (1.12–1.15)
Household income level 0.779
 Low 1 1.30 (0.86–1.96)
 High 1 1.41 (0.98–2.03)
Marital status 0.231
 Married 1 1.09 (0.76–1.57)
 Single 1 1.52 (1.02–2.25)
Regular physical activity 0.118
 No 1 1.38 (1.04–1.85)
 Yes 1 0.68 (0.29–1.57)
Alcohol consumption 0.486
 No 1 1.17 (0.63–2.15)
 Yes 1 1.48 (1.09–2.00)
Obesity 0.021
 No 1 1.71 (1.20–2.45)
 Yes 1 0.90 (0.59–1.36)
Stress 0.862
 No 1 1.03 (0.67–1.58)
 Yes 1 1.08 (0.75–1.57)
Depression 0.512
 No 1 1.12 (0.83–1.52)
 Yes 1 1.45 (0.71–2.95)
Hypertension 0.113
 No 1 1.49 (1.10–2.00)
 Yes 1 0.81 (0.41–1.61)
Diabetes mellitus 0.547
 No 1 1.33 (1.00–1.77)
 Yes 1 0.99 (0.39–2.49)
Dyslipidemia 0.026
 No 1 1.43 (1.07–1.91)
 Yes 1 0.54 (0.24–1.20)
Cardiovascular diseases 0.134
 No 1 1.36 (1.03–1.79)
 Yes 1 0.50 (0.14–1.83)
Cancers 0.093
 No 1 1.34 (1.02–1.76)
 Yes 1 0.20 (0.02–1.79)

HRQoL, health-related quality of life.

* Adjusted for age, education, occupation, residential area, household income, marital status, physical activity, alcohol consumption, obesity, stress, depression, hypertension, diabetes mellitus, dyslipidemia, cardiovascular diseases, and cancers.

REFERENCES

1. World Health Organization. Programme on mental health: WHOQOL user manual. Geneva: World Health Organization; 2012.

2. Centers for Disease Control and Prevention. Measuring healthy days: population assessment of health-related quality of life. Atlanta (GA): Centers for Disease Control and Prevention; 2001.

3. Fayers PM, Machin D. Quality of life: the assessment, analysis and reporting of patient-reported outcomes. 3rd ed. Chichester: John Wiley & Sons; 2016.

4. Strandberg AY, Strandberg TE, Pitkala K, Salomaa VV, Tilvis RS, Miettinen TA. The effect of smoking in midlife on health-related quality of life in old age: a 26-year prospective study. Arch Intern Med 2008;168:1968-74.
crossref pmid
5. McClave AK, Dube SR, Strine TW, Mokdad AH. Associations between health-related quality of life and smoking status among a large sample of U.S. adults. Prev Med 2009;48:173-9.
crossref pmid
6. Lopez-Nicolas A, Trapero-Bertran M, Munoz C. Smoking, health-related quality of life and economic evaluation. Eur J Health Econ 2018;19:747-56.
crossref pmid pdf
7. World Health Organization. WHO report on the global tobacco epidemic, 2021: addressing new and emerging products. Geneva: World Health Organization; 2021.

8. Choi S, Lee K, Park SM. Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study. Circulation 2021;144:1528-38.
crossref pmid
9. Patel D, Davis KC, Cox S, Bradfield B, King BA, Shafer P, et al. Reasons for current E-cigarette use among U.S. adults. Prev Med 2016;93:14-20.
crossref pmid pmc
10. Vandrevala T, Coyle A, Walker V, Cabrera Torres J, Ordona I, Rahman P. ‘A good method of quitting smoking’ or ‘just an alternative to smoking’? Comparative evaluations of e-cigarette and traditional cigarette usage by dual users. Health Psychol Open 2017;4:2055102916684648.
crossref pmid pmc pdf
11. Maglia M, Caponnetto P, Di Piazza J, La Torre D, Polosa R. Dual use of electronic cigarettes and classic cigarettes: a systematic review. Addict Res Theory 2018;26:330-8.
crossref
12. Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open 2018;1:e185937.
crossref pmid pmc
13. Martinez U, Martinez-Loredo V, Simmons VN, Meltzer LR, Drobes DJ, Brandon KO, et al. How does smoking and nicotine dependence change after onset of vaping?: a retrospective analysis of dual users. Nicotine Tob Res 2020;22:764-70.
crossref pmid pdf
14. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
crossref pmid
15. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009;12:1187-93.
crossref pmid
16. Vogl M, Wenig CM, Leidl R, Pokhrel S. Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 2012;12:203.
crossref pmid pmc pdf
17. Cheng X, Jin C. The association between smoking and health-related quality of life among Chinese individuals aged 40 years and older: a cross-sectional study. Front Public Health 2022;10:779789.
crossref pmid pmc
18. Lim MT, Sung HN, Seo HJ, Kim SG, Chang DM, Pack HJ, et al. Smoking and health-related quality of life among Korean adults. Korean J Fam Pract 2015;5:135-42.

19. Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation: the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008;201:225-35.
crossref pmid
20. Cai J, Bidulescu A. Associations between e-cigarette use or dual use of ecigarette and combustible cigarette and metabolic syndrome: results from the National Health and Nutrition Examination Survey (NHANES). Ann Epidemiol 2023;85:93-9.
crossref pmid
21. Wang JB, Olgin JE, Nah G, Vittinghoff E, Cataldo JK, Pletcher MJ, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One 2018;13:e0198681.
crossref pmid pmc
22. Osei AD, Mirbolouk M, Orimoloye OA, Dzaye O, Uddin SM, Benjamin EJ, et al. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am J Med 2019;132:949-54.
crossref pmid
23. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009;49:57-71.
crossref pmid pmc
24. Arias HR, Targowska-Duda KM, Garcia-Colunga J, Ortells MO. Is the antidepressant activity of selective serotonin reuptake inhibitors mediated by nicotinic acetylcholine receptors? Molecules 2021;26:2149.
crossref pmid pmc
25. Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry 2010;196:440-6.
crossref pmid
26. Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav 2013;3:302-26.
crossref pmid pmc
27. Park SH, Lee L, Shearston JA, Weitzman M. Patterns of electronic cigarette use and level of psychological distress. PLoS One 2017;12:e0173625.
crossref pmid pmc
28. Piper ME, Kenford S, Fiore MC, Baker TB. Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt. Ann Behav Med 2012;43:262-70.
crossref pmid
29. Moayeri F, Hsueh YA, Dunt D, Clarke P. Smoking cessation and quality of life: insights from analysis of longitudinal Australian data, an application for economic evaluations. Value Health 2021;24:724-32.
crossref pmid


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
INFORMATION FOR AUTHORS AND REVIEWERS
Editorial Office
Room 2003, Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
Tel: +82-2-3210-1537    Tax: +82-2-3210-1538    E-mail: kjfm@kafm.or.kr                

Copyright © 2024 by Korean Academy of Family Medicine.

Developed in M2PI

Close layer
prev next